LRRK2 levels in immune cells are increased in Parkinson’s disease

Código QR

LRRK2 levels in immune cells are increased in Parkinson’s disease

Immune system regulation: A known suspect High levels of leucine-rich repeat kinase 2 (LRRK2) in immune cells disrupt immune system function in patients with Parkinson’s disease (PD). Mutations in LRRK2 are the most common genetic cause of PD. Although LRRK2 is found in many immune cells, research e...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	D. A. Cook, G. T. Kannarkat, A. F. Cintron, Laura M. Butkovich, Kyle B. Fraser, J. Chang, N. Grigoryan, S. A. Factor, Andrew B. West, J. M. Boss, M. G. Tansey
Formato:	article
Lenguaje:	EN
Publicado:	Nature Portfolio 2017
Materias:	Neurology. Diseases of the nervous system RC346-429
Acceso en línea:	https://doaj.org/article/6c926ddf8a1d4b89b93c4407e58bb695
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Is LRRK2 the missing link between inflammatory bowel disease and Parkinson’s disease?
por: Mary K. Herrick, et al.
Publicado: (2021)

Loss of Parkinson’s susceptibility gene LRRK2 promotes carcinogen-induced lung tumorigenesis
por: Chandra Lebovitz, et al.
Publicado: (2021)

Transcriptome analysis in LRRK2 and idiopathic Parkinson’s disease at different glucose levels
por: Rubén Fernández-Santiago, et al.
Publicado: (2021)

Astrocytic atrophy as a pathological feature of Parkinson’s disease with LRRK2 mutation
por: Paula Ramos-Gonzalez, et al.
Publicado: (2021)

LRRK2 inhibitors and their potential in the treatment of Parkinson’s disease: current perspectives
por: Atashrazm F, et al.
Publicado: (2016)

LRRK2 kinase activity is dependent on LRRK2 GTP binding capacity but independent of LRRK2 GTP binding.
por: Jean-Marc Taymans, et al.
Publicado: (2011)

LRRK2 kinase activity regulates lysosomal glucocerebrosidase in neurons derived from Parkinson’s disease patients
por: Daniel Ysselstein, et al.
Publicado: (2019)

Parkinson’s disease patient-specific neuronal networks carrying the LRRK2 G2019S mutation unveil early functional alterations that predate neurodegeneration
por: G. Carola, et al.
Publicado: (2021)

A motif within the armadillo repeat of Parkinson’s-linked LRRK2 interacts with FADD to hijack the extrinsic death pathway
por: Nasia Antoniou, et al.
Publicado: (2018)

The Gordon Research Seminar & Conference on Parkinson’s disease: state of the Science 200 years after James Parkinson’s essay on the Shaking Palsy
por: J. T. Greenamyre, et al.
Publicado: (2017)

Cryo-EM analysis of homodimeric full-length LRRK2 and LRRK1 protein complexes
por: Kushal Sejwal, et al.
Publicado: (2017)

A homologue of the Parkinson’s disease-associated protein LRRK2 undergoes a monomer-dimer transition during GTP turnover
por: Egon Deyaert, et al.
Publicado: (2017)

Variable frequency of LRRK2 variants in the Latin American research consortium on the genetics of Parkinson’s disease (LARGE-PD), a case of ancestry
por: Mario Cornejo-Olivas, et al.
Publicado: (2017)

Differences in MTHFR and LRRK2 variant’s association with sporadic Parkinson’s disease in Mexican Mestizos correlated to Native American ancestry
por: Elizabeth Romero-Gutiérrez, et al.
Publicado: (2021)

Phosphorylation of 4E-BP1 in the mammalian brain is not altered by LRRK2 expression or pathogenic mutations.
por: Alzbeta Trancikova, et al.
Publicado: (2012)

Understanding LRRK2 kinase activity in preclinical models and human subjects through quantitative analysis of LRRK2 and pT73 Rab10
por: Xiang Wang, et al.
Publicado: (2021)

Inhibition of LRRK2 kinase activity promotes anterograde axonal transport and presynaptic targeting of α-synuclein
por: Charlotte F. Brzozowski, et al.
Publicado: (2021)

Deletion of lrrk2 causes early developmental abnormalities and age-dependent increase of monoamine catabolism in the zebrafish brain.
por: Stefano Suzzi, et al.
Publicado: (2021)

LRRK2 regulates retrograde synaptic compensation at the Drosophila neuromuscular junction
por: Jay Penney, et al.
Publicado: (2016)

The IkappaB kinase family phosphorylates the Parkinson's disease kinase LRRK2 at Ser935 and Ser910 during Toll-like receptor signaling.
por: Nicolas Dzamko, et al.
Publicado: (2012)

The gut-brain axis: is intestinal inflammation a silent driver of Parkinson’s disease pathogenesis?
por: Madelyn C. Houser, et al.
Publicado: (2017)

Mutación del gen LRRK2 se asocia a presentación autosómica dominante de la enfermedad de Parkinson en una familia chilena
por: Miranda C,Marcelo
Publicado: (2007)

Cerebrospinal fluid biomarkers in Parkinson’s disease with freezing of gait: an exploratory analysis
por: J. M. Hatcher-Martin, et al.
Publicado: (2021)

Fine-mapping, gene expression and splicing analysis of the disease associated LRRK2 locus.
por: Daniah Trabzuni, et al.
Publicado: (2013)

Exploring human-genome gut-microbiome interaction in Parkinson’s disease
por: Zachary D. Wallen, et al.
Publicado: (2021)

LRRK2 kinase regulates α-synuclein propagation via RAB35 phosphorylation
por: Eun-Jin Bae, et al.
Publicado: (2018)

Ubiqutination via K27 and K29 chains signals aggregation and neuronal protection of LRRK2 by WSB1
por: Frederick C. Nucifora, et al.
Publicado: (2016)

Aberrant Patterns of Sensory-Evoked Activity in the Olfactory Bulb of LRRK2 Knockout Mice
por: Andrea Maset, et al.
Publicado: (2021)

Integrated molecular landscape of Parkinson’s disease
por: C. J. H. M. Klemann, et al.
Publicado: (2017)

Abnormal center of mass feedback responses during balance: A potential biomarker of falls in Parkinson's disease.
por: J Lucas McKay, et al.
Publicado: (2021)

INCREASING NOISE IMMUNITY OF CABLES FOR FIRE PROTECTION SYSTEMS
por: G. V. Bezprozvannych, et al.
Publicado: (2020)

INCREASED SPONTANEOUS APOPTOSIS OF PERIPHERAL BLOOD LYMPHOCYTES FROM PATIENTS WITH PARKINSON’S DISEASE
por: S. N. Pchelina, et al.
Publicado: (2014)

COMPLEMENT SYSTEM AS A MARKER OF IMMUNE DYSFUNCTION IN CHILDREN AUTISM SPECTRUM DISORDERS
por: E. G. Cheremnykh, et al.
Publicado: (2019)

Parkinson’s disease managing reversible neurodegeneration
por: Hinz M, et al.
Publicado: (2016)

Cooperative genome-wide analysis shows increased homozygosity in early onset Parkinson's disease.
por: Javier Simón-Sánchez, et al.
Publicado: (2012)

Early constipation predicts faster dementia onset in Parkinson’s disease
por: M. Camacho, et al.
Publicado: (2021)

Sex-based differences in the activation of peripheral blood monocytes in early Parkinson disease
por: Samantha M. Carlisle, et al.
Publicado: (2021)

Parkinson's disease managing reversible neurodegeneration [Corrigendum]
por: Hinz M, et al.
Publicado: (2016)

Parkinson’s Disease Managing Reversible Neurodegeneration [Retraction]
por: Hinz M, et al.
Publicado: (2020)

Parkinson’s Disease Managing Reversible Neurodegeneration [Expression of Concern]
por: Hinz M, et al.
Publicado: (2020)